Building on our legacy of ambitious climate action goals, Pfizer is committing to achieve Net-Zero across our value chain by 2040.
We recognise global climate change as one of the defining issues of our time requiring collective action to mitigate the risks it poses, such as increased adverse impacts on human health and decreased access to critical medicines and vaccines due to disruptions in value chains caused by the greater frequency of severe weather.
Pfizer is continuing its near-term commitment to reduce company Greenhouse Gas (GHG) emissions aligned with a 1.5⁰C trajectory and to engage suppliers so that they also set science-based GHG emissions reduction goals.
In June 2022, Pfizer announced a broader commitment to further reduce GHG emissions by working to achieve the voluntary Net-Zero Standard by 2040, ten years earlier than the timeline described in the standard.1
By 2040 Pfizer aims to decrease its company GHG emissions by 95% and its value chain emissions by 90% from 2019 levels through accelerating the transition away from fossil fuels and engaging suppliers to catalyse equivalent action.
We have set the following mid-term targets on the journey to our Net-Zero 2040 goals:
Reduce scope 1 and 2 Greenhouse Gas emissions by 46% by 2030 (from a 2019 baseline)
Source 80% of electricity from renewables by 2025, and 100% by 2030
Reduce emissions from upstream transportation and distribution by 10% and from business travel by 25% by 2025 (from a 2019 baseline)
Accelerate change across our supply chain, driving 64% of our suppliers (by spend) to also set science-based GHG emission reduction goals by 2025
Forward-Looking Information
This webpage includes forward-looking statements about, amongst other things, our performance on Environmental, Social and Governance (ESG) topics and our ESG strategy, goals and targets that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Please refer to Pfizer's Annual Report on Form 10-K for the year ended December 31, 2022, and Pfizer's subsequent reports on Form 10-Q, including the sections thereof captioned "Risk Factors" and "Forward-Looking Information and Factors That May Affect Future Results," as well as Pfizer's subsequent reports on Form 8-K for a description of the substantial risks and uncertainties related to the forwardlooking statements included in this webpage. The forward-looking statements in this webpage speak only as of the original date of this document, and we undertake no obligation to update or revise any of these statements, as the result of new information or future events or developments or otherwise.
RESPONSIBILITY
Leveraging our strengths in scientific innovation to reduce the environmental impact of our medicines.
RESPONSIBILTY
As a company with a global presence, we are committed to making a difference in local communities and the world around us.
References